Mahickra Chem.

Why is Mahickra Chemicals Ltd falling/rising?

As of 25-Aug, Mahickra Chemicals Ltd's stock price is rising to 288.00, reflecting strong performance with a year-to-date gain of 93.87%. Despite a decline in investor participation, the stock remains above its moving averages, indicating a positive trend.

As of 25-Aug, Mahickra Chemicals Ltd's stock price is rising, currently at 288.00, reflecting an increase of 3.05 (1.07%). This upward movement can be attributed to several factors. The stock has shown strong performance over the past month, with a gain of 11.65%, significantly outperforming the Sensex, which only increased by 2.39% during the same period. Year-to-date, the stock has surged by 93.87%, while the Sensex has declined by 6.87%, indicating robust investor confidence in Mahickra Chemicals Ltd.<BR><BR>Additionally, the stock is trading above its moving averages across multiple time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, which typically signals a positive trend. Furthermore, the stock has outperformed its sector by 1.33% today, reinforcing its strong market position. However, it is worth noting that there has been a decline in investor participation, with delivery volume falling by 48.9% compared to the 5-day average. Despite this drop in participation, the overall performance metrics suggest that the stock is on an upward trajectory.

Which are the latest news on Mahickra Chem.?

Who are in the management team of Mahickra Chem.?

The management team of Mahickra Chem includes Miteshkumar Champaklal Gandhi (Chairman & Managing Director), Ashishkumar Champaklal Gandhi and Komal Mitesh Gandhi (Whole-time Directors), Amisha Fenil Shah, Niren Atinbhai Desai, and Basari Mehta (Independent Directors), along with Sona Bachani (Company Secretary & Compliance Officer).

The management team of Mahickra Chem includes the following individuals:<BR><BR>1. **Miteshkumar Champaklal Gandhi** - Chairman & Managing Director<BR>2. **Ashishkumar Champaklal Gandhi** - Whole-time Director<BR>3. **Komal Mitesh Gandhi** - Whole-time Director<BR>4. **Amisha Fenil Shah** - Independent Director<BR>5. **Sona Bachani** - Company Secretary & Compliance Officer<BR>6. **Niren Atinbhai Desai** - Independent Director<BR>7. **Basari Mehta** - Independent Director<BR><BR>If you have any more questions about the company or its operations, feel free to ask!

What does Mahickra Chem. do?

Mahickra Chemicals Ltd manufactures Reactive Dyes and operates in the Chemicals & Petrochemicals industry as a Micro Cap company. Established in 1994 and converted to a Public Limited Company in 2017, it has a market cap of INR 255 Cr.

Overview:<BR>Mahickra Chemicals Ltd is engaged in the manufacturing of Reactive Dyes and operates within the Chemicals & Petrochemicals industry, classified as a Micro Cap company.<BR><BR>History:<BR>Mahickra Chemicals Ltd was originally established as a Partnership Firm named 'Mahak Dye Chem Industries' in 1994 and was converted into a Public Limited Company on November 13, 2017. The company has been manufacturing Reactive Dyes since 1998, while trading in Reactive Dyes commenced in 1994. Revenue and profit data for the latest quarter are not available.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: N/A<BR>Most recent Net Profit: N/A<BR>Market-cap value: INR 255 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 54.00<BR>Industry P/E: 44<BR>Dividend Yield: 0.03%<BR>Debt-Equity: -0.01<BR>Return on Equity: 7.72%<BR>Price-to-Book: 3.82<BR><BR>Contact Details:<BR>Address: Plot No 1209 Phase-3, GIDC Vatva Ahmedabad Gujarat : 382445<BR>Tel: 91-079-25890811/25832692<BR>Email: info@mahickra.com<BR>Website: http://www.mahickra.com

Who are the peers of the Mahickra Chem.?

Mahickra Chem.'s peers include Shri Ahimsa, Sanginita Chemi., Ushanti Colour, and others, with varying management risks and growth rates. Sanginita Chemi. leads in 1-year returns at 440.44%, while Mahickra Chem. has a return of 102.16%.

Peers: The peers of Mahickra Chem. are Shri Ahimsa, Sanginita Chemi., Ushanti Colour, Hi-Green Carbon, Arvee Laborat., Indian Phosphate, Vital Chemtech, Jocil, Par Drugs & Che.<BR><BR>Quality Snapshot: Excellent management risk is observed at Shri Ahimsa and Indian Phosphate, while Average management risk is found at Mahickra Chem. and Jocil, and the rest have Below Average management risk. Growth is Below Average for Mahickra Chem., Sanginita Chemi., Ushanti Colour, Hi-Green Carbon, Arvee Laborat., Vital Chemtech, and the rest, while Shri Ahimsa and Indian Phosphate have Average growth, and no peers have Excellent growth. In terms of Capital Structure, Excellent ratings are seen at Shri Ahimsa, Indian Phosphate, Jocil, and Par Drugs & Che., while Good is noted for Arvee Laborat., Average for Hi-Green Carbon, and Below Average for Mahickra Chem., Sanginita Chemi., Ushanti Colour, Vital Chemtech, and the rest.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Sanginita Chemi. at 440.44%, while Hi-Green Carbon has the lowest at -36.05%. Mahickra Chem.'s 1-year return of 102.16% is significantly higher than Hi-Green Carbon's but lower than Sanginita Chemi.'s. Additionally, Hi-Green Carbon and Arvee Laborat. have negative six-month returns.

How big is Mahickra Chem.?

As of 14th August, Mahickra Chemicals Ltd has a market capitalization of 280.00 Cr, classifying it as a Micro Cap company. There is no valid financial data available for the latest four quarters regarding Net Sales and Net Profit, with Shareholder's Funds at 35.70 Cr and Total Assets at 68.28 Cr as of March 2025.

As of 14th August, <BR><BR>Market Cap: Mahickra Chemicals Ltd has a market capitalization of 280.00 Cr, classifying it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: There is no valid financial data available for the latest four quarters regarding Net Sales and Net Profit.<BR><BR>Balance Sheet Snapshot: The reporting period is March 2025, with Shareholder's Funds amounting to 35.70 Cr and Total Assets totaling 68.28 Cr.

How has been the historical performance of Mahickra Chem.?

Mahickra Chem. has shown mixed historical performance, with net sales increasing to 88.16 Cr in March 2025 but declining from previous years, while profit metrics improved. However, the company faces challenges in revenue stability and cash flow management.

Answer:<BR>The historical performance of Mahickra Chem. shows fluctuations in key financial metrics over the past four years.<BR><BR>Breakdown:<BR>Mahickra Chem. reported net sales of 88.16 Cr in March 2025, an increase from 71.92 Cr in March 2024, but a decline from 103.03 Cr in March 2023 and 102.30 Cr in March 2022. Total operating income mirrored this trend, reaching 88.16 Cr in March 2025. The raw material cost rose significantly to 80.93 Cr in March 2025 from 62.06 Cr in March 2024, while total expenditure also increased to 85.66 Cr in March 2025. Operating profit (PBDIT) improved to 5.12 Cr in March 2025, up from 2.95 Cr in March 2024, but down from 6.05 Cr in March 2023. Profit before tax was 3.53 Cr in March 2025, compared to 1.50 Cr in March 2024, while profit after tax increased to 2.53 Cr from 1.07 Cr. The earnings per share (EPS) rose to 3.12 in March 2025 from 1.32 in March 2024. On the balance sheet, total assets increased to 68.28 Cr in March 2025, up from 60.78 Cr in March 2024, with total liabilities also rising to 68.28 Cr. Cash flow from operating activities showed no inflow in March 2025, reflecting a challenging cash position. Overall, Mahickra Chem. has experienced a mixed performance with improvements in profit metrics but challenges in revenue stability and cash flow management.

Is Mahickra Chem. overvalued or undervalued?

As of August 28, 2025, Mahickra Chem. is considered very expensive with a PE ratio of 48.12 and other high valuation metrics, indicating overvaluation compared to peers and raising concerns about its growth prospects despite a strong recent performance.

As of 28 August 2025, Mahickra Chem. has moved from a fair valuation to very expensive, indicating a significant shift in its perceived market value. The company is currently overvalued, with a PE ratio of 48.12, an EV to EBITDA of 54.07, and a Price to Book Value of 3.65. These ratios suggest that the stock is trading at a premium compared to its earnings and book value, which raises concerns about sustainability.<BR><BR>In comparison to its peers, Mahickra Chem.'s valuation stands out as particularly high; for instance, Godrej Industries, which is rated attractive, has a PE ratio of 41.86, while Solar Industries, also very expensive, trades at a PE of 99.06. The disparity in these valuations highlights that Mahickra Chem. is not only overvalued relative to its immediate competitors but also raises questions about its growth prospects given its low ROCE of 4.71% and ROE of 7.59%. Notably, Mahickra Chem. has outperformed the Sensex in various time frames, including a 39.05% return over the past year, which may contribute to the inflated valuation despite the underlying financial metrics suggesting caution.

Who are the top shareholders of the Mahickra Chem.?

The top shareholders of Mahickra Chem include Ashishkumar Champaklal Gandhi with 16.23%, individual investors with 41.69%, and the National Stock Exchange Of India Limited Account Karvy Stock Broking Limited at 2.22%. There are no pledged promoter holdings or mutual funds involved.

The top shareholders of Mahickra Chem include Ashishkumar Champaklal Gandhi, who holds the largest stake at 16.23%. Additionally, individual investors collectively own 41.69% of the shares. The highest public shareholder is the National Stock Exchange Of India Limited Account Karvy Stock Broking Limited, with a holding of 2.22%. There is also one Foreign Institutional Investor (FII) that holds 0.59% of the shares. Notably, there are no pledged promoter holdings and no mutual funds involved.

What is the technical trend for Mahickra Chem.?

As of June 3, 2025, Mahickra Chem's trend is mildly bullish, supported by a bullish weekly MACD and Bollinger Bands, despite mixed signals from the KST, Dow Theory, RSI, and OBV.

As of 3 June 2025, the technical trend for Mahickra Chem has changed from bullish to mildly bullish. The weekly MACD remains bullish, supported by bullish signals from the Bollinger Bands and daily moving averages. However, the KST shows a mildly bearish stance on the monthly timeframe, and the Dow Theory indicates a bearish trend on the weekly chart. The RSI shows no signal on both weekly and monthly timeframes, and the OBV is mildly bearish on the weekly. Overall, the current stance is mildly bullish, driven primarily by the weekly MACD and Bollinger Bands, despite some mixed signals from other indicators.

When is the next results date for Mahickra Chem.?

No Upcoming Board Meetings

Has Mahickra Chem. declared dividend?

Mahickra Chemicals Ltd has declared a 2% dividend, amounting to ₹0.2 per share, with an ex-date of March 18, 2025. The company has shown strong total returns across various periods, including a 70.68% total return over the last 5 years.

Mahickra Chemicals Ltd has declared a 2% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 2%<BR>- Amount per share: 0.2<BR>- Ex-date: 18 Mar 25<BR><BR>Dividend Yield: 0.16%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, Mahickra Chemicals Ltd experienced a price return of 12.44%, a dividend return of 0.19%, resulting in a total return of 12.63%.<BR><BR>Over the past year, the company achieved a price return of 9.91%, a dividend return of 0.18%, leading to a total return of 10.09%.<BR><BR>In the 2-year period, the price return was 43.36%, with a dividend return of 0.62%, culminating in a total return of 43.98%.<BR><BR>For the 3-year period, the company reported a price return of 54.53%, a dividend return of 1.58%, which resulted in a total return of 56.11%.<BR><BR>In the last 4 years, Mahickra Chemicals Ltd had a price return of 35.71%, with a dividend return of 1.93%, bringing the total return to 37.64%.<BR><BR>Over the 5-year period, the price return was 68.04%, alongside a dividend return of 2.64%, resulting in a total return of 70.68%.<BR><BR>Overall, Mahickra Chemicals Ltd has declared a modest dividend while demonstrating strong total returns across various periods, indicating a positive performance trend for investors.